Medical Developments (Australia) Performance
| MVP Stock | 0.68 0.08 10.53% |
Medical Developments holds a performance score of 10 on a scale of zero to a hundred. The company secures a Beta (Market Risk) of -0.0435, which conveys not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Medical Developments are expected to decrease at a much lower rate. During the bear market, Medical Developments is likely to outperform the market. Use Medical Developments coefficient of variation, jensen alpha, and the relationship between the downside deviation and standard deviation , to analyze future returns on Medical Developments.
Risk-Adjusted Performance
OK
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Medical Developments International are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Medical Developments unveiled solid returns over the last few months and may actually be approaching a breakup point. ...more
Ex Dividend Date 2020-03-05 |
1 | Global robot density in factories doubled in seven years - Todays Medical Developments | 11/28/2024 |
2 | Medical Developments International to Announce FY25 Half-Year Results - TipRanks | 02/11/2025 |
| Begin Period Cash Flow | 24.7 M |
Medical |
Medical Developments Relative Risk vs. Return Landscape
If you would invest 42.00 in Medical Developments International on November 29, 2024 and sell it today you would earn a total of 26.00 from holding Medical Developments International or generate 61.9% return on investment over 90 days. Medical Developments International is generating 1.1103% of daily returns assuming 8.6054% volatility of returns over the 90 days investment horizon. Simply put, 76% of all stocks have less volatile historical return distribution than Medical Developments, and 78% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Medical Developments Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Medical Developments' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Medical Developments International, and traders can use it to determine the average amount a Medical Developments' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.129
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | MVP | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 8.61 actual daily | 76 76% of assets are less volatile |
Expected Return
| 1.11 actual daily | 22 78% of assets have higher returns |
Risk-Adjusted Return
| 0.13 actual daily | 10 90% of assets perform better |
Based on monthly moving average Medical Developments is performing at about 10% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Medical Developments by adding it to a well-diversified portfolio.
Medical Developments Fundamentals Growth
Medical Stock prices reflect investors' perceptions of the future prospects and financial health of Medical Developments, and Medical Developments fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Medical Stock performance.
| Return On Equity | -0.45 | ||||
| Return On Asset | -0.0123 | ||||
| Profit Margin | (0.78) % | ||||
| Operating Margin | 0.06 % | ||||
| Current Valuation | 60.57 M | ||||
| Shares Outstanding | 112.66 M | ||||
| Price To Book | 1.37 X | ||||
| Price To Sales | 1.97 X | ||||
| Revenue | 33.15 M | ||||
| Gross Profit | 28.08 M | ||||
| EBITDA | (29.45 M) | ||||
| Net Income | (40.99 M) | ||||
| Cash And Equivalents | 24.66 M | ||||
| Total Debt | 2.29 M | ||||
| Book Value Per Share | 0.49 X | ||||
| Cash Flow From Operations | (10.78 M) | ||||
| Earnings Per Share | (0.46) X | ||||
| Total Asset | 59.16 M | ||||
| Retained Earnings | (62.86 M) | ||||
About Medical Developments Performance
Assessing Medical Developments' fundamental ratios provides investors with valuable insights into Medical Developments' financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Medical Developments is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Medical Developments is entity of Australia. It is traded as Stock on AU exchange.Things to note about Medical Developments performance evaluation
Checking the ongoing alerts about Medical Developments for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Medical Developments help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Medical Developments is way too risky over 90 days horizon | |
| Medical Developments has some characteristics of a very speculative penny stock | |
| Medical Developments appears to be risky and price may revert if volatility continues | |
| The company reported the revenue of 33.15 M. Net Loss for the year was (40.99 M) with profit before overhead, payroll, taxes, and interest of 28.08 M. | |
| Medical Developments International has accumulated about 24.66 M in cash with (10.78 M) of positive cash flow from operations. | |
| Roughly 18.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from news.google.com: Medical Developments International to Announce FY25 Half-Year Results - TipRanks |
- Analyzing Medical Developments' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Medical Developments' stock is overvalued or undervalued compared to its peers.
- Examining Medical Developments' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Medical Developments' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Medical Developments' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Medical Developments' stock. These opinions can provide insight into Medical Developments' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Medical Stock Analysis
When running Medical Developments' price analysis, check to measure Medical Developments' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medical Developments is operating at the current time. Most of Medical Developments' value examination focuses on studying past and present price action to predict the probability of Medical Developments' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medical Developments' price. Additionally, you may evaluate how the addition of Medical Developments to your portfolios can decrease your overall portfolio volatility.